Conference abstract
An 8-year evolution of the level of control of cardiovascular risk factors on a group of patients living with type 2 diabetes in a specialized center in Yaoundé
Pan African Medical Journal - Conference Proceedings. 2021:11(16).20
Jan 2021.
doi: 10.11604/pamj-cp.2021.11.16.922
Archived on: 20 Jan 2021
Contact the corresponding author
Keywords: Diabete de type 2, cardiovascular risk factor, control
Oral presentation
An 8-year evolution of the level of control of cardiovascular risk factors on a group of patients living with type 2 diabetes in a specialized center in Yaoundé
Antoinette Assiga Ntsama1,&, Mesmin Dehayem1,2, Batakeh Ba Agoons3, Eugène Sobngwi1,3,4
1National obesity center, Endocrine and metabolic diseases Unit, Central hospital, Yaoundé Cameroon, 2Faculty of Health Siences, University of Bamenda, Bamenda, Cameroon, 3Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon, 4Biotechnology center, Yaoundé, Cameroon
&Corresponding author
Introduction: the leading cause of death in type 2 diabetes is of cardiovascular origin. Assessing the level of control of cardiovascular risk factors over time seems essential in optimizing the management of people with type 2 diabetes and reducing mortality. Methods: we conducted 2 cross-sectional descriptive studies at the national obesity center of the Yaoundé Central Hospital in 2010 and 2018 involving 205 and 180 patients with type 2 diabetes respectively. The level of control of glycaemia, blood pressure and cholesterol was evaluated and interpreted according to the American Diabetes Association standards. Results: the 2010 sample included 89 males and 116 females aged 57 years [29-85], while the 2018 Sample included 51 males and 129 females aged 60 years [32-86]. In the 2010 sample, 57.6% were treated with an oral antidiabetic regimen exclusively, vs 58.9% in 2018. 39.5% were treated with an oral antidiabetic-insulin combination in 2011, vs 41.1% in 2018. Optimal HbA1c control (<7%) was achieved in 40.4% of the subjects in 2010, and in 61.1% in 2018. Optimal blood pressure control (< 140/90 mmHg) was achieved in 35.1% in 2010 and 62.8% in 2018. Lipid control was optimal in 68.9% and 87.2% for total cholesterol, in 38% and 53.3% for LDL in 2010 and 2018 respectively. Regular physical activity was carried out by 56.8% in 2010 and 37.8% in 2018. Conclusion: we observed a satisfactory evolution of glycaemic, blood pressure and cholesterol control. Nevertheless, the practice of regular physical activity has decreased, suggesting a major emphasis on pharmacologic measures over time.
An 8-year evolution of the level of control of cardiovascular risk factors on a group of patients living with type 2 diabetes in a specialized center in Yaoundé
Antoinette Assiga Ntsama1,&, Mesmin Dehayem1,2, Batakeh Ba Agoons3, Eugène Sobngwi1,3,4
1National obesity center, Endocrine and metabolic diseases Unit, Central hospital, Yaoundé Cameroon, 2Faculty of Health Siences, University of Bamenda, Bamenda, Cameroon, 3Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon, 4Biotechnology center, Yaoundé, Cameroon
&Corresponding author
Introduction: the leading cause of death in type 2 diabetes is of cardiovascular origin. Assessing the level of control of cardiovascular risk factors over time seems essential in optimizing the management of people with type 2 diabetes and reducing mortality. Methods: we conducted 2 cross-sectional descriptive studies at the national obesity center of the Yaoundé Central Hospital in 2010 and 2018 involving 205 and 180 patients with type 2 diabetes respectively. The level of control of glycaemia, blood pressure and cholesterol was evaluated and interpreted according to the American Diabetes Association standards. Results: the 2010 sample included 89 males and 116 females aged 57 years [29-85], while the 2018 Sample included 51 males and 129 females aged 60 years [32-86]. In the 2010 sample, 57.6% were treated with an oral antidiabetic regimen exclusively, vs 58.9% in 2018. 39.5% were treated with an oral antidiabetic-insulin combination in 2011, vs 41.1% in 2018. Optimal HbA1c control (<7%) was achieved in 40.4% of the subjects in 2010, and in 61.1% in 2018. Optimal blood pressure control (< 140/90 mmHg) was achieved in 35.1% in 2010 and 62.8% in 2018. Lipid control was optimal in 68.9% and 87.2% for total cholesterol, in 38% and 53.3% for LDL in 2010 and 2018 respectively. Regular physical activity was carried out by 56.8% in 2010 and 37.8% in 2018. Conclusion: we observed a satisfactory evolution of glycaemic, blood pressure and cholesterol control. Nevertheless, the practice of regular physical activity has decreased, suggesting a major emphasis on pharmacologic measures over time.
